Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to $137.9 million.

  • Avidity Biosciences' Shares Outstanding (Diluted Average) rose 1176.9% to $137.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.9 million, marking a year-over-year increase of 1176.9%. This contributed to the annual value of $111.6 million for FY2024, which is 5282.69% up from last year.
  • Latest data reveals that Avidity Biosciences reported Shares Outstanding (Diluted Average) of $137.9 million as of Q3 2025, which was up 1176.9% from $129.6 million recorded in Q2 2025.
  • Avidity Biosciences' 5-year Shares Outstanding (Diluted Average) high stood at $137.9 million for Q3 2025, and its period low was $37.6 million during Q2 2021.
  • Over the past 5 years, Avidity Biosciences' median Shares Outstanding (Diluted Average) value was $72.2 million (recorded in 2023), while the average stood at $80.0 million.
  • As far as peak fluctuations go, Avidity Biosciences' Shares Outstanding (Diluted Average) skyrocketed by 9123.85% in 2021, and later soared by 1176.9% in 2025.
  • Avidity Biosciences' Shares Outstanding (Diluted Average) (Quarter) stood at $41.4 million in 2021, then grew by 25.91% to $52.2 million in 2022, then surged by 39.97% to $73.0 million in 2023, then skyrocketed by 52.83% to $111.6 million in 2024, then increased by 23.58% to $137.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $137.9 million in Q3 2025, compared to $129.6 million in Q2 2025 and $129.2 million in Q1 2025.